7 Signs Your Pharmaceutical Supply Chain May Need Customs Broker Support

By Your Health Magazine Contributor

Your Health Magazine Contributor

More Essential Business Tools For Marketing Healthcare Articles

7 Signs Your Pharmaceutical Supply Chain May Need Customs Broker Support

Running a pharmaceutical supply chain is no small feat. Between managing temperature-sensitive shipments, navigating strict regulatory requirements, and keeping up with ever-changing import and export rules, there is a lot that can go wrong. And when it does, the consequences go beyond financial losses — delays in pharmaceutical products can directly impact patient health.

The question many pharmaceutical businesses face is: how do you know when your in-house team is stretched too thin and it is time to bring in outside expertise? The answer often lies in the warning signs hiding in plain sight within your daily operations.

Mentioned below are several signs indicating your pharmaceutical supply chain may need customs broker support.

1. Your Shipments Are Frequently Delayed at the Border

If your pharmaceutical shipments are regularly held up at customs, that is a red flag. Delays at the border usually point to documentation errors, incorrect tariff classifications, or missing regulatory certificates. For pharmaceutical products, this is particularly serious — temperature-controlled medicines can be rendered ineffective if held in non-compliant storage conditions during an unexpected delay. Recurring border holds suggest your current process needs a professional review.

2. You Are Struggling to Keep Up With Regulatory Changes

Pharmaceutical trade regulations are among the most complex and frequently updated in any industry. Import permits, drug establishment licences, Health Canada or FDA requirements, and country-specific phytosanitary rules can change with little notice. If your team is constantly scrambling to keep up — or worse, discovering compliance gaps after the fact — it is a clear sign you need dedicated expertise in your corner.

3. You Have Received Unexpected Fines or Penalties

Customs fines and penalties do not just hurt your bottom line — they can also damage your reputation with regulatory authorities. Common triggers include misdeclared goods, incorrect country-of-origin claims, and failure to meet import licensing requirements. If you have received even one unexpected fine, it is worth asking whether your compliance processes are robust enough to handle the volume and complexity of your pharmaceutical shipments.

4. Your Documentation Is Inconsistent or Error-Prone

Pharmaceutical shipments require a precise set of documents — commercial invoices, certificates of analysis, import permits, packing lists, and more. A single error or missing form can cause a cascade of delays and compliance issues. If your team is regularly catching mistakes at the last minute, or if errors are slipping through altogether, it is time to consider whether a specialist should be managing your trade documentation.

5. You Are Expanding Into New Markets

Entering a new country means learning an entirely new set of customs rules, import restrictions, and pharmaceutical licensing requirements. What works smoothly in your current markets may not apply elsewhere. Many pharmaceutical companies find their biggest compliance headaches occur during international expansion, when teams are already stretched managing growth. This is one of the most common — and most avoidable — reasons supply chains run into trouble.

According to the World Health Organization, approximately 1 in 10 medical products in low- and middle-income countries is substandard or falsified — a statistic that underscores just how critical proper regulatory oversight and supply chain integrity are when moving pharmaceutical products across borders.

6. Your Team Lacks Pharmaceutical Trade Expertise

General logistics knowledge is valuable, but pharmaceutical trade comes with a very specific set of rules that generalist teams are not always equipped to handle. Controlled substances, biologics, cold-chain requirements, and special import permits all require specialist knowledge. If your logistics or compliance team is spending more time researching pharmaceutical regulations than managing operations, that is a sign the workload has outgrown your current setup.

Some pharmaceutical companies choose to work with customs brokers, such as Livingston International, to help navigate trade compliance requirements, customs documentation, and cross-border logistics.

7. Your Supply Chain Costs Are Creeping Up Unexpectedly

Unexpected cost increases in your supply chain are often a symptom of underlying compliance or classification issues. Overpaying on duties due to incorrect tariff codes, absorbing storage costs from customs holds, or paying premium freight rates to compensate for delays — these are all signs that inefficiencies are costing you more than they should. A specialist can often identify savings opportunities that more than offset the cost of their support.

Final Takeaway

If any of these signs sound familiar, you are not alone. Pharmaceutical supply chains are genuinely complex, and the regulatory landscape keeps getting more demanding. The good news is that recognising the problem early gives you the opportunity to fix it before it causes serious disruption.

Start by auditing your last six months of shipments. Look for patterns — recurring delays, similar documentation errors, or cost spikes tied to specific trade lanes. Then consider whether your current team has the bandwidth and expertise to address those patterns, or whether bringing in a specialist partner would give you faster, more reliable results.

The pharmaceutical industry moves fast, and so do the rules that govern how its products cross borders. Having the right support in place is not a luxury — it is a safeguard for your business, your supply chain partners, and ultimately, the patients who depend on your products reaching them safely and on time.